Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | APP | P05067 | 1/20 | 0.41 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.33 |
| ▸ | PDE4A | P27815 | 1/20 | 0.33 |
| ▸ | LMNA | P02545 | 1/20 | 0.33 |
| ▸ | SLC6A6 | P31641 | 1/20 | 0.33 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.33 |
| ▸ | BLM | P54132 | 1/20 | 0.33 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.32 |
| ▸ | DNM1 | Q05193 | 2/20 | 0.31 |
| ▸ | SLC22A2 | O15244 | 1/20 | 0.31 |
| ▸ | SLC22A1 | O15245 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11244311 | 0.93 | APP (0.42) | APPPTGS1PDE4ALMNASLC6A6 | |
| SCHEMBL739462 | 0.88 | DNM1 (0.35) | APPEPHX2DNM1SLC22A2SLC22A1 | |
| SCHEMBL7803583 | 0.83 | PTGS1 (0.38) | APPPTGS1PDE4ALMNASLC6A6 | |
| SCHEMBL9785036 | 0.82 | SLC22A1 (0.48) | DNM1SLC22A2SLC22A1 | |
| SCHEMBL11879878 | 0.82 | SLC22A1 (0.48) | DNM1SLC22A2SLC22A1 | |
| Betaine SCHEMBL11241340 | 0.82 | TSHR (0.42) | LMNAEPHX2DNM1 | |
| SCHEMBL1608022 | 0.80 | BBOX1 (0.45) | LMNAEPHX2DNM1 | |
| SCHEMBL35194 | 0.80 | SLC22A1 (0.52) | EPHX2DNM1SLC22A2SLC22A1 | |
| SCHEMBL29506651 | 0.80 | SLC22A1 (0.56) | EPHX2DNM1SLC22A2SLC22A1 | |
| SCHEMBL10138705 | 0.80 | SLC22A1 (0.56) | EPHX2DNM1SLC22A2SLC22A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2430195-B1 | COMPOSITIONS AND METHODS FOR BIOLOGICAL SAMPLE STORAGE | BIOMATRICA INC (US) | 2019-01-23 | — | — | EP | disclosed |
| US-20140065627-A1 | COMPOSITIONS AND METHODS FOR BIOLOGICAL SAMPLE STORAGE | BIOMATRICA, INC. (US) | 2014-03-06 | — | — | US | disclosed |
| US-20140065627-A1 | COMPOSITIONS AND METHODS FOR BIOLOGICAL SAMPLE STORAGE | BIOMATRICA, INC. (US) | 2014-03-06 | — | — | US | disclosed |
| US-8519125-B2 | Compositions and methods for biological sample storage | BIOMATRICA, INC. (US) | 2013-08-27 | — | — | US | disclosed |
| US-8519125-B2 | Compositions and methods for biological sample storage | BIOMATRICA, INC. (US) | 2013-08-27 | — | — | US | disclosed |
| EP-2430195-A2 | COMPOSITIONS AND METHODS FOR BIOLOGICAL SAMPLE STORAGE | Biomatrica, INC. (US) | 2012-03-21 | — | — | EP | disclosed |
| US-20110081363-A1 | COMPOSITIONS AND METHODS FOR BIOLOGICAL SAMPLE STORAGE | BIOMATRICA, INC. (US) | 2011-04-07 | — | — | US | disclosed |
| US-20110081363-A1 | COMPOSITIONS AND METHODS FOR BIOLOGICAL SAMPLE STORAGE | BIOMATRICA, INC. (US) | 2011-04-07 | — | — | US | disclosed |
| WO-2010132508-A2 | COMPOSITIONS AND METHODS FOR BIOLOGICAL SAMPLE STORAGE | BIOMATRICA, INC. (US) | 2010-11-18 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110081363-A1 | COMPOSITIONS AND METHODS FOR BIOLOGICAL SAMPLE STORAGE | DNASE1, DIS3, NEFM | APP 2662/4885PTGS1 4345/4885PDE4A 3207/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.